McAdam LLC Buys 77 Shares of Agilent Technologies, Inc. (NYSE:A)

McAdam LLC raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 2,531 shares of the medical research company’s stock after purchasing an additional 77 shares during the quarter. McAdam LLC’s holdings in Agilent Technologies were worth $376,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Western Pacific Wealth Management LP increased its position in shares of Agilent Technologies by 18.9% during the first quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock worth $64,000 after purchasing an additional 70 shares in the last quarter. Haverford Trust Co increased its position in shares of Agilent Technologies by 1.7% during the first quarter. Haverford Trust Co now owns 4,423 shares of the medical research company’s stock worth $644,000 after purchasing an additional 74 shares in the last quarter. Menard Financial Group LLC increased its position in shares of Agilent Technologies by 1.6% in the 2nd quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after acquiring an additional 77 shares during the period. Global Retirement Partners LLC increased its position in shares of Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after acquiring an additional 79 shares during the period. Finally, Marshall Financial Group LLC increased its position in shares of Agilent Technologies by 1.0% in the 3rd quarter. Marshall Financial Group LLC now owns 8,243 shares of the medical research company’s stock valued at $1,224,000 after acquiring an additional 82 shares during the period. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on A. Barclays upped their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. Bank of America upped their target price on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Evercore ISI upped their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Wolfe Research downgraded Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Finally, UBS Group upped their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $144.36.

Agilent Technologies Trading Down 1.7 %

A stock opened at $130.72 on Friday. The company’s 50-day simple moving average is $140.91 and its 200-day simple moving average is $138.59. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.35. The firm has a market cap of $38.14 billion, a P/E ratio of 30.90, a PEG ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.43 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were paid a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is presently 22.22%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,995 shares of company stock valued at $1,739,510. 0.33% of the stock is owned by corporate insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.